Xiangxue Pharma (XPH) announced plans to build a cell-therapy production facility in Guangzhou using GE Healthcare’s prefabricated FlexFactory™ technology. The company will offer CDMO manufacturing services to other pharmas. Although known mainly for its TCM products, XPH has a subsidiary, Xiangxue Life Sciences (XLifeSc), that provides technology to develop T cell receptor products. GE said the XPH factory, which will be operational in March 2019, is the first use of its prefab factory for T Cell products.
Source: China Biotoday
